简体中文 | 繁體中文 | English

Press Releases

2014-03-27 13:50 Quintiles Announces Exercise of the Underwriters’ Option to Purchase Additional Secondary Shares
2014-03-27 12:18 Sonic Foundry Announces Partnership in China
2014-03-27 11:15 SmartStream Issues Strategy Paper on Intraday Liquidity and its Implications on Financial Institutions
2014-03-26 17:11 Toshiba Launches Interface Bridge ICs That Support Next Generation Content Security Technology, SeeQVault™
2014-03-26 16:34 FTV Capital Closes Oversubscribed Growth Equity Fund
2014-03-26 11:46 First Data Brings on First Developer Licensee for its VisionPLUS and AccessPLUS Suite of Products
2014-03-26 11:39 Havok’s Technology Powers Tencent Games’ Upcoming Title, Iron Knight
2014-03-26 10:27 Toshiba Launches 1W and 0.6W White LEDs for LED Lighting
2014-03-26 10:15 Over 3000 visitors participated in CARTES SECURE CONNEXIONS Asia in Hong Kong
2014-03-26 10:00 The world’s top mail system SmarterTools and China’s leading mail solution brand Yienter join hands for cooperation
2014-03-25 17:58 Traders Hotels Launches PressReader, Offering Guests Access to 2,500+ Newspapers and Magazines
2014-03-25 17:50 PMI Expands Focus on Requirements Management
2014-03-25 17:40 Intelligent Energy and GIC: GIC invests $63* million in Intelligent Energy
2014-03-25 17:31 Cinemaxx Selects MasterImage 3D for Rollout of 3D Screens in Indonesia
2014-03-25 16:52 Emoderation launches in Australia and APAC with regional HQ in Sydney
2014-03-25 16:38 EnVerv Announces Closing of $15.4M Series C Investment Round
2014-03-25 16:13 Toshiba Starts Sample Shipments of Regulator ICs for Automotive Applications
2014-03-25 15:00 Otsuka Pharmaceutical's Samsca® Approved in Japan as the World's First Drug Therapy for ADPKD, a Rare Kidney Disease
2014-03-25 14:58 Oral OTEZLA® (apremilast) Demonstrated Clinically Meaningful and Sustained Improvements in Skin, Nail and Scalp of Adult Patients with Moderate to Severe Plaque Psoriasis
2014-03-25 14:47 OTEZLA® (apremilast) – First Oral Therapy Approved by the U.S. Food and Drug Administration for the Treatment of Adults with Active Psoriatic Arthritis

Business Wire Weibo

Industries

Latest Releases